Sinonasal cancer patients wanted for Long-Term observation study
NCT ID NCT04755855
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study follows 200 sinonasal cancer patients over time to understand how the disease progresses, how treatments affect survival, and how patients feel. Researchers will also analyze tumor genetics to learn more about the cancer's molecular makeup. No new treatments are being tested—this is purely an observation and data-gathering effort.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Participants
-
About 200 people
The number the study aims to enrol. It can still change while the study runs.
- Started
-
Jan 2021
- Expected to finish
-
Jan 2031
An estimate. End dates often move.
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
Who is studied
Patients undergoing treatment for sinonasal cancers
- Ages
-
30 days to 99 years
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Subjects between the ages of 30 days (non-inclusive) and 99 years (inclusive) * Patients with a diagnosis of sinonasal cancer * Patients undergoing treatment at Mayo Clinic Exclusion Criteria: * Healthy individuals * Unwilling to sign the informed consent
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Sinonasal carcinoma are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
How to take part
Only the study team decides who joins. These are the ways to reach them.
-
The study's own enquiry address
This study publishes an address for enquiries. See it below .
-
The places running it
1 site. The list below names each one and where it is.
-
The official record
ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.
-
A doctor treating you
A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Email: •••••@•••••
Locations
-
Mayo Clinic in Rochester
RECRUITINGRochester, Minnesota, 55905, United States
Contact Email: •••••@•••••
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Experimental drug tazemetostat offered to patients with rare, aggressive tumors
- Rare sinus cancer study aims to clarify treatment outcomes
- Radiation-Free hope: study tests if surgery alone is enough for rare nasal cancer
- New drug duo aims to make inoperable sinus cancer removable
- New drug combo shows promise for Tough-to-Treat head and neck cancer
- New chemo approach may spare sinus cancer patients from major surgery